Endpoints News· @endpts · X·· 7 小时前精选AI 评分62
AI 导读
艾伯维将向Disco支付4000万美元首付款,交易总额最高可达25.4亿美元,用于为其ADC和T细胞衔接器项目寻找实体瘤靶点。该合作聚焦实体瘤靶点发现,具体里程碑与分成条款未在材料中披露。
推荐理由
这笔交易把首付款与里程碑金额并列,读者可据此判断跨国药企为补强实体瘤靶点所付出的对价结构。
正文
AbbVie will pay Disco $40M upfront in a deal worth up to $2.54B to find solid tumor targets for its ADC and T cell engager programs. https://endpoints.news/abbvvie-and-disco-strike-deal-worth-more-than-2-5b-for-solid-tumor-targets/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com